Literature DB >> 28762251

Helicobacter pylori management in ASEAN: The Bangkok consensus report.

Varocha Mahachai1,2, Ratha-Korn Vilaichone3,2, Rapat Pittayanon1,2, Jarin Rojborwonwitaya4, Somchai Leelakusolvong5, Monthira Maneerattanaporn5,2, Peranart Chotivitayatarakorn3,2, Sombat Treeprasertsuk1, Chomsri Kositchaiwat6, Pises Pisespongsa7, Pisaln Mairiang8, Aziz Rani9, Alex Leow10, Swe Mon Mya11, Yi-Chia Lee12, Sengdao Vannarath13, Bouachanh Rasachak13, Oung Chakravuth14, Moe Myint Aung11, Tiing-Leong Ang15, Jose D Sollano16, Duc Trong Quach17, Inchaya Sansak18, Olarn Wiwattanachang18, Piyathida Harnsomburana19, Ari Fahrial Syam20, Yoshio Yamaoka21, Kwong-Ming Fock22, Khean-Lee Goh10, Kentaro Sugano23, David Graham24.   

Abstract

Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. H. pylori management in ASEAN: the Bangkok consensus report gathered key opinion leaders for the region to review and evaluate clinical aspects of H. pylori infection and to develop consensus statements, rationales, and grades of recommendation for the management of H. pylori infection in clinical practice in ASEAN countries. This ASEAN Consensus consisted of 34 international experts from 10 ASEAN countries, Japan, Taiwan, and the United States. The meeting mainly focused on four issues: (i) epidemiology and disease association; (ii) diagnostic tests; (iii) management; and (iv) follow-up after eradication. The final results of each workshop were presented for consensus voting by all participants. Statements, rationale, and recommendations were developed from the available current evidence to help clinicians in the diagnosis and treatment of H. pylori and its clinical diseases.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ASEAN countries; Helicobacter pylori; consensus

Mesh:

Substances:

Year:  2018        PMID: 28762251     DOI: 10.1111/jgh.13911

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  27 in total

Review 1.  Helicobacter pylori Infection: New Facts in Clinical Management.

Authors:  Peter Malfertheiner; Marino Venerito; Christian Schulz
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

2.  Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.

Authors:  David Y Graham; Hong Lu; Maria Pina Dore
Journal:  Helicobacter       Date:  2018-11-15       Impact factor: 5.753

3.  Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans.

Authors:  Christie Y Jeon; Yu-Chen Lin; Samuel J Klempner; Bechien U Wu; Sungjin Kim; Kevin M Waters; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-19

4.  Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study.

Authors:  Helia Alavifard; Nasrin Mirzaei; Abbas Yadegar; Kaveh Baghaei; Sinéad Marian Smith; Amir Sadeghi; Mohammad Reza Zali
Journal:  Curr Microbiol       Date:  2020-11-30       Impact factor: 2.188

Review 5.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

6.  Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation.

Authors:  Jung Wook Lee; Su Jin Kim; Cheol Woong Choi; Hyeong Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

7.  Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".

Authors:  Negin Kashani; Amin Talebi Bezmin Abadi
Journal:  Gastroenterol Res Pract       Date:  2018-02-20       Impact factor: 2.260

Review 8.  Current understanding and management of Helicobacter pylori infection: an updated appraisal.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  F1000Res       Date:  2018-06-11

9.  Prevalence and Pattern of Antibiotic Resistant Strains of Helicobacter Pylori Infection in ASEAN

Authors:  Ratha Korn Vilaichone; Duc Trong Quach; Yoshio Yamaoka; Ken Sugano; Varocha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26

10.  Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.